Vaccinations

University of Oxford launches first human aerosol TB vaccine trial

The University of Oxford has commenced a new clinical trial called TB-45, which will test the safety of a new tuberculosis (TB) vaccine.

Nepal faces 1200% increase in COVID cases

Nepal, which shares a long border with hard-hit India, is experiencing a meteoric rise in COVID-19 cases and facing an oxygen shortage.

Testing must go hand-in-hand with vaccines to come out of the crisis

COVID-19 testing must go hand-in-hand with the vaccines in order for the UK to come out of the crisis successfully.

What happens now that the US supports the TRIPS waiver?

Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.

Research reveals five reasons behind UK vaccine hesitancy

New data explores why some in the UK continue to experience vaccine hesitancy - with one man explaining that "it is human nature to have second thoughts".

Under 40s will be offered an alternative to the Astrazeneca vaccine

The Joint Committee on Vaccination and Immunisation (JCVI) has advised that all under 40s should be offered an alternative to the Oxford/AstraZeneca vaccine following blood clot risk.

European Commission hesitates on TRIPS waiver for pandemic

The European Commission on Thursday (6 May) responded to a US declaration of support for the TRIPS waiver, stating that they were open to further discussions without explicit agreement.

Dementia patients should be given priority for the COVID-19 vaccine

Alzheimer Europe has issued a call for people with dementia and their carers to be given priority for the COVID-19 vaccine.

Only 41% of people are willing to sign up for COVID-19 vaccine trials

New research from the University of Birmingham shows that only 41% of people would be willing to sign up for COVID-19 vaccine trials.

CureVac mRNA vaccine can be stored at normal fridge temperature

The CureVac mRNA vaccine is currently in final stages of clinical trials - but it is expected to perform like Pfizer and Moderna, with the bonus of surviving at ordinary refrigeration temperatures.

Countries denied access to vaccines they helped develop

A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.

US declares support for TRIPS waiver on COVID vaccines

The TRIPS waiver would temporarily stop an intellectual property law that stops poorer countries to manufacture the vaccine - the US now joins India and South Africa in the proposal.

Fully vaccinated UK adults to get COVID booster dose in 2021

Adults over the age of 50 in the UK could get the COVID booster dose in 2021 - the third dose of the vaccine could be given as soon as Autumn.

COVID-19 variant vaccines will be fast-tracked through cutting-edge testing centre

Health Secretary Matt Hancock has announced that vaccines tailored to tackle COVID-19 variants will be fast-tracked through new state-of-the-art labs.

Doctors stop vaccine-blood clot with heparin alternative

A patient with vaccine-inducted thrombotic thrombocytopenia was successfully treated with a heparin alternative, after receiving the Johnson & Johnson vaccine.

Social media users more likely to believe COVID-19 conspiracy theories

A study by Annenberg Public Policy Center (APPC) researchers has found that users of conservative and social media are more likely to believe COVID-19 conspiracy theories.

Single COVID-19 vaccine protects against variants in those with previous infection

A new study has found that a single dose of the COVID-19 vaccine boosts protection against SARS-CoV-2 variants, but only in those with previous infection.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders